Letter from the Vice President Corporate
Affairs Philip Morris European Union Region to the Clerk of the
Committee (TB 19B)
Further to my letter of 20 January 2000 I am
now able to furnish you with the financial data referred to in
your letter of 14 January 2000.
In my response of 20 January 2000 I provided
you with the amounts expended by Philip Morris in developing the
Accord product and our denicotinized cigarette.
In 1999, the total operating expenses of the
departments in our tobacco affiliates, worldwide that fund research
and development was in excess $180,000,000. This represents approximately
5 per cent. of the Philip Morris tobacco affiliates' turnover
and approximately 2 per cent of the tobacco affilates' net income.
26 January 2000
| 
